GlaxoSmithKline
Clayton Youngs

Employees
◦ 110,000 in 117 countries

Pharmaceuticals
◦ GSK Holds about 7% of the Market Share
◦ Research and Development of vaccines and
medicines
◦ Over the counter products
 Aquafresh, Nicorette, TUMS
Industry and Background






JP Garnier is Chief Executive Officer of GlaxoSmithKline.
He assumed this role in January 2001 with the merger of
SmithKline Beecham and Glaxo Wellcome.
Rupert Bondy was appointed Senior Vice President and
General Counsel for GlaxoSmithKline in June 2001.
John Clarke assumed the role of President, Consumer
Healthcare, GlaxoSmithKline in January 2006.
Russell Greig assumed the role of President,
Pharmaceuticals International for GlaxoSmithKline in March
2003.
Julian Heslop assumed the role of Chief Financial Officer
for GlaxoSmithKline in April 2005.
Bill Louv was appointed Senior Vice President, Information
Technology and Chief Information Officer, GlaxoSmithKline,
in January 2007.
Key People
Financial Analysis
Three Main Areas of IT
 Research and Development
 Global Manufacturing
 Supply IT
Bioinformaticians
- Biology and Computer Science
Information Technology


3 year graduate development program
Can focus on:
◦
◦
◦
◦
◦

Project management
Business analysis
Strategy and architecture
Business process improvement
Service management
Skills Needed:
◦ Networking, influencing, leadership, teamwork,
critical analytical thinking, technical aptitude,
passion
IT Development Program